Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Technosphere/Insulin, Insulin Lispro and Exubera on Endogenous Glucose Production in Type 2 Diabetes
2006-004489-15Phase 2Completed
- Sponsor
- MannKind
- Start
- Apr 2007
- Countries
- 1
01
Overview
Phase 2 trial of Technosphere insulin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by MannKind. Primary endpoint: Endogenous Glucose Production parameters after meal challenge. Started Apr 2007; status: completed.
02
Drugs
Technosphere insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-004489-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004489-15.